Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at rapid speed.

Merck CEO Rob Davis told CNBC’s Jim Cramer that there’s more to the pharmaceutical giant than its lucrative cancer drug, Keytruda.

Stocks in Focus This Week. In this article, we are going to take a look at where Citigroup Inc. (NYSE:C) stands against the ...

Stocks in Focus This Week. In this article, we are going to take a look at where Wells Fargo & Company (NYSE:WFC) stands ...

Sean Boyd, the chair of Agnico Eagle Mines (TSX: AEM; NYSE: AEM), recalled when the company’s performance prompted CNN’s Mad ...

Stocks in Focus This Week. In this article, we are going to take a look at where Schlumberger Limited (NYSE:SLB) stands ...

For this article, we compiled a list of 12 stocks that were discussed by Jim Cramer during the episode of Mad Money on ...

The European Union’s top diplomat Kaja Kallas said Ukraine’s allies should work toward lowering the price cap on Russian oil ...

Turkey's Pasifik Holding plans more cooperation in the global technology sector and also seeks to invest in port operations, ...

We recently compiled a list of the 10 Firms Drop on Bearish Statements, Disappointing Earnings. In this article, we are going ...

Kraft Heinz, Ralph Lauren, Opera, Aspen Aerogels, Arbutus, Alaska Air, KKR, and Crown Castle. Special counsel report on ...